Sort
16,300 grants matching “fatty liver disease”
Using a Rare Disease Model to Explore the Role of FGF21 in Insulin Resistance
$162,305Stephen Isaac Stone · Washington University · K08 · FY2021 · DK
In vivo regulation of lipid flux in the etiology of NAFLD and Insulin Resistance
$162,216Daniel Vatner · Yale University · K23 · FY2019 · DK
New Approaches to the Evaluation and Treatment of Acromegaly
$162,166Pamela U Freda · Columbia University Health Sciences · K24 · FY2010 · DK
Developmental effects of intestinal microbes on metabolic and behavioral circadian rhythms
$162,025Vanessa Anne Leone · University Of Wisconsin-Madison · R21 · FY2023 · DK
Patient-Oriented Research on Hepatitis in Special Populations
$162,019Raymond T Chung · Massachusetts General Hospital · K24 · FY2007 · DK
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility
$162,000Giuseppe Cullaro · University Of California, San Francisco · K23 · FY2023 · DK
Central regulation of atherosclerosis by testosterone-deficiency
$162,000Mauricio D Dorfman · University Of Washington · K01 · FY2022 · HL
Central regulation of atherosclerosis by testosterone-deficiency
$162,000Mauricio D Dorfman · University Of Washington · K01 · FY2023 · HL
Modulation of the biliary immune niche by the microbiome
$162,000Claire E O'Leary · University Of Wisconsin-Madison · K22 · FY2023 · AI
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility
$162,000Giuseppe Cullaro · Columbia University Health Sciences · K23 · FY2025 · DK
Central regulation of atherosclerosis by testosterone-deficiency
$162,000Mauricio D Dorfman · University Of Washington · K01 · FY2021 · HL
Central regulation of atherosclerosis by testosterone-deficiency
$162,000Mauricio D Dorfman · University Of Washington · K01 · FY2024 · HL
Prevention of Ground Pad During Radiofrequency Tumor Ablation
$161,990Dieter Haemmerich · Medical University Of South Carolina · R01 · FY2011 · CA
Signatures of dysfunctional mitochondrial fatty acid oxidation that predispose to early-onset preeclampsia
$161,984Kathryn Johnson Gray · Massachusetts General Hospital · K08 · FY2020 · HL
Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4)
$161,934Jessica Rose Wilson · University Of Pennsylvania · K23 · FY2020 · HL
Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4) (Grant Transfer from UPENN)
$161,934Jessica Rose Wilson · Mayo Clinic Jacksonville · K23 · FY2023 · HL
GENE EXPRESSION AND GENOTYPING FACILITY
$161,922Stanton L Gerson · Case Western Reserve University · P30 · FY2014 · CA
Core 1: Metabolomics
$161,850David Anderson Scott · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2024 · CA
Macronutrients, Mitochondria and Blood Metabolome/Proteome Disease Risk Profiles
$161,820Bruce S Kristal · Brigham And Women'S Hospital · U01 · FY2010 · ES
Epigenetic mechanisms linking in utero cadmium exposure to hepatic steatosis
$161,730Michael Cowley · North Carolina State University Raleigh · K22 · FY2019 · ES
Epigenetic mechanisms linking in utero cadmium exposure to hepatic steatosis
$161,730Michael Cowley · North Carolina State University Raleigh · K22 · FY2018 · ES
Epigenetic mechanisms linking in utero cadmium exposure to hepatic steatosis
$161,730Michael Cowley · North Carolina State University Raleigh · K22 · FY2017 · ES
Role of Sumoylation in Alcoholic Liver Disease
$161,568Maria Lauda Tomasi · Cedars-Sinai Medical Center · K01 · FY2016 · AA
Role of sumoylation in alcoholic liver disease
$161,568Maria Lauda Tomasi · University Of Southern California · K01 · FY2013 · AA
Role of Sumoylation in Alcoholic Liver Disease
$161,568Maria Lauda Tomasi · Cedars-Sinai Medical Center · K01 · FY2015 · AA